期刊
CANCER RESEARCH
卷 75, 期 6, 页码 950-962出版社
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-14-0992
关键词
-
类别
资金
- CDMRP PCRP award [W81XWH12-1-0206]
- NCI/NIH [RO1CA101904-08S1, P50CA16042]
- UCLA Cota Robles fellowship
- CDMRP Prostate Cancer Training Award [W81XWH-11-1-0505]
- NIH Tumor Immunology Training Grant [5T32CA009120]
- UCLA/Caltech MSTP [T32GM008042]
- Plexxikon Co.
Growing evidence suggests that tumor-associated macrophages (TAM) promote cancer progression and therapeutic resistance by enhancing angiogenesis, matrix-remodeling, and immunosuppression. In this study, prostate cancer under androgen blockade therapy (ABT) was investigated, demonstrating that TAMs contribute to prostate cancer disease recurrence through paracrine signaling processes. ABT induced the tumor cells to express macrophage colony-stimulating factor 1 (M-CSF1 or CSF1) and other cytokines that recruit and modulate macrophages, causing a significant increase in TAM infiltration. Inhibitors of CSF1 signaling through its receptor, CSF1R, were tested in combination with ABT, demonstrating that blockade of TAM influx in this setting disrupts tumor promotion and sustains a more durable therapeutic response compared with ABT alone. (C)2015 AACR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据